These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6849446)

  • 21. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trial of tricyclic antidepressant in RDC schizoaffective disorder, depressed type.
    Pi EH; Simpson GM
    Hillside J Clin Psychiatry; 1983; 5(1):23-9. PubMed ID: 6662492
    [No Abstract]   [Full Text] [Related]  

  • 24. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.
    Gwirtsman HE; Szuba MP; Toren L; Feist M
    Psychopharmacol Bull; 1994; 30(2):157-64. PubMed ID: 7831449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of desipramine on body weight in depression.
    Levitt AJ; Joffe RT; Esche I; Sherret D
    J Clin Psychiatry; 1987 Jan; 48(1):27-8. PubMed ID: 3804981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of methylphenidate.
    Myers WC; Stewart JT
    Hosp Community Psychiatry; 1989 Jul; 40(7):754-5. PubMed ID: 2777235
    [No Abstract]   [Full Text] [Related]  

  • 28. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.
    Nelson JC; Price LH; Jatlow PI
    Am J Psychiatry; 1986 Sep; 143(9):1151-4. PubMed ID: 3752299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of desipramine-refractory depression.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature].
    Buhagiar K; Cassar J
    Turk Psikiyatri Derg; 2007; 18(2):179-83. PubMed ID: 17566884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of desipramine in depressed inpatients.
    Nelson JC
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):10-6. PubMed ID: 6384205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
    Parker G; Brotchie H
    Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test and response to methylphenidate in depression.
    Sternbach H; Gwirtsman H; Gerner RH
    Am J Psychiatry; 1981 Dec; 138(12):1629-31. PubMed ID: 7304800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacologic treatment of depression.
    Extein I; Gold MS; Pottash AL
    Psychiatr Clin North Am; 1984 Sep; 7(3):503-17. PubMed ID: 6148743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of desipramine in ICU cancer patients for acute depression.
    Thangathurai D; Roffey P; Mogos M; Riad M; Mikhail M
    J Palliat Care; 2004; 20(4):326. PubMed ID: 15690838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.